One-year Prevalence, Comorbidities, and Cost of Hospitalizations for Alpha-1 Antitrypsin Deficiency among Patients with Chronic Obstructive Pulmonary Disease in the United States
**Objectives:** Little is known about severe chronic obstructive pulmonary disease (COPD) exacerbations among patients with Alpha-1 Antitrypsin Deficiency (AATD). We assessed inpatients with AATD and COPD among a sample of COPD inpatients to ascertain demographic, clinical and economic differences i...
Main Authors: | Christopher M. Blanchette, Emily Zacherle, Joshua M. Noone, Bryce A. Van Doren, Debosree Roy, Reuben Howden |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia Data Analytics, LLC
|
Series: | Journal of Health Economics and Outcomes Research |
Online Access: | http://jheor.scholasticahq.com/article/9799-one-year-prevalence-comorbidities-and-cost-of-hospitalizations-for-alpha-1-antitrypsin-deficiency-among-patients-with-chronic-obstructive-pulmonary-disease-in-the-united-states.pdf |
Similar Items
-
The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
by: Basiri Z, et al.
Published: (2011-03-01) -
The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
by: E Nadi, et al.
Published: (2011-04-01) -
The Prevalence of the Alpha-1 Antitrypsin Deficiency in Patients with Chronic Obstructive Pulmonary Disease
by: E Nadi
Published: (2012-05-01) -
One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA
by: Susan T Arthur, et al.
Published: (2014-07-01) -
Alpha- 1 Antitrypsin Deficiency in Children: Pulmonary Involvement
by: Mohammad Esmaeili, et al.
Published: (2015-02-01)